Clinical trial
The Role of Prostaglandins in the Progression of Diabetic Retinopathy and the Therapeutic Efficacy of Topical Ketorolac (Acuvail)
NCT01609881 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Prostaglandins in the Progression of Diabetic Retinopathy and the Therapeutic Efficacy of Topical Ketorolac (Acuvail)
- Lead sponsor
- Vanderbilt University
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- March 31, 2012
- Completion date
- October 19, 2016
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.